Anne Khodarkovskaya

1 presentation

• W2. GALANTAMINE-MEMANTINE COMBINATION REGULATING THE KYNURENINE PATHWAY METABOLISM IN THE TREATMENT OF POST-STROKE DEPRESSION AND POST-STROKE COGNITIVE IMPAIRMENTS AND PREVENTION OF STROKE

  2026 ASCP Annual Meeting